Results 141 to 150 of about 261,861 (299)
The role of the mean curvature in the immersion theory of surfaces [PDF]
Howard W. Alexander
openalex +1 more source
Emerging role of ARHGAP29 in melanoma cell phenotype switching
This study gives first insights into the role of ARHGAP29 in malignant melanoma. ARHGAP29 was revealed to be connected to tumor cell plasticity, promoting a mesenchymal‐like, invasive phenotype and driving tumor progression. Further, it modulates cell spreading by influencing RhoA/ROCK signaling and affects SMAD2 activity. Rho GTPase‐activating protein
Beatrice Charlotte Tröster +3 more
wiley +1 more source
RACHILYSIS: A METHOD OF TREATING THE SEVERER FORMS OF LATERAL CURVATURE. [PDF]
Richard Barwell
openalex +1 more source
In this exploratory study, we investigated the relationship between the gut microbiota and outcome in patients with metastatic hormone receptor‐positive breast cancer, treated in a randomized clinical trial with chemotherapy alone or chemotherapy in combination with immune checkpoint blockade.
Andreas Ullern +7 more
wiley +1 more source
Calculation of stress in electrodeposits from the curvature of a plated strip
Abner Brenner, S. Senderoff
openalex +1 more source
A SUCCESSFUL CASE OF GASTRECTOMY FOR CARCINOMA OF THE PYLORUS AND LESSER CURVATURE OF THE STOMACH, [PDF]
G. A. Syme
openalex +1 more source
A bioinformatics screen identifies TCF19 as an aggressiveness‐sustaining gene in prostate cancer
Gene expression meta‐analysis in multiple prostate cancer patient cohorts identifies Transcription factor 19 (TCF19) as an aggressiveness‐sustaining gene with prognostic potential. TCF19 is a gene repressed by androgen signaling that sustains core cancer‐related processes such as vascular permeability or tumor growth and metastasis.
Amaia Ercilla +15 more
wiley +1 more source
ON THE POSITIVITY OF THE RICCI CURVATURE, OF THE SECTIONAL CURVATURE AND OF THE CURVATURE OPERATOR [PDF]
openaire +1 more source
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser +14 more
wiley +1 more source

